Skip to content
stoqly

KBR

KBR NYSE Diversified Support Services Financials FY2016–FY2025

KBR's revenue rose 1.0% to $7.8 billion in fiscal 2025. Its operating margin was 10.0%, up from 8.6% a year earlier. Free cash flow was $515 million, up 25.6%. It paid out $413 million in dividends and buybacks, 80% of free cash flow. The diluted share count fell 3.7%.

Last close Β· Oct 23, 2026

$39.23

0.8%
Revenue Total sales reported in the income statement.
$7.8B
1.0% vs prior year
Operating margin Operating income as a share of revenue.
10.0%
1.4 pts
Net income Profit after all expenses, interest and tax.
$415M
10.7%
Free cash flow Cash from operations minus capital spending.
$515M
25.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
15.8%
1.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$5.0B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
11.8x
On $3.33 EPS (TTM)

What KBR does

No business description yet.

Legal name
KBR, Inc.
Fiscal year ends
January 2, 2026
Latest annual report
β€”
Accession Β· CIK
0001357615-26-000051
0001357615

Revenue and margins

KBR had $7.8B of revenue in fiscal 2025, up 1.0% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $515M in fiscal 2025, 6.6% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

KBR returned $413M to shareholders in fiscal 2025, 80% of free cash flow. The diluted share count fell 3.7%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value KBR yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$2.1B and divides by 129.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 11.8x Β· peers 22.4x Β· sector 26.0x.

Balance sheet

Cash, debt and the ratios that show how comfortably KBR can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $370M$389M$304M$342M$500M
Debt incl. finance leases $1.9B$1.8B$1.9B$2.6B$2.6B
Net debt / EBITDA 4.1x2.9x2.6x2.8x2.2x
Debt / equity 1.1x1.1x1.3x1.8x1.7x
Interest coverage 2.9x3.9x3.9x4.6x4.9x
Current ratio 1.2x1.0x1.1x1.1x1.2x
Quick ratio 1.2x1.0x1.1x1.1x1.2x
Total assets $6.2B$5.6B$5.6B$6.7B$6.6B
Total liabilities $4.5B$3.9B$4.2B$5.2B$5.1B
Shareholders' equity $1.7B$1.6B$1.4B$1.5B$1.5B
Net debt (βˆ’ = net cash) $1.5B$1.4B$1.5B$2.2B$2.1B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.9M

4 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

DateInsiderTradeSharesPriceValueFiling
May 20, 2026 Jack B MooreDirector Bought 4,000 $31.44 $0.1M Form 4
May 19, 2026 Carlos A. SabaterDirector Bought 14,500 $32.47 $0.5M Form 4
May 14, 2026 Thaer Lewis VonDirector Bought 3,000 $30.77 $0.1M Form 4
May 13, 2026 Shad E. EvansEVP & Chief Financial Officer Bought 8,375 $30.60 $0.3M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ• βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ• βœ“ βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ• βœ“
Current ratio rose βœ“ βœ“ βœ“
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose βœ“ βœ“ βœ“
Revenue rose relative to assets βœ“ βœ“ βœ•
F-score 6 / 98 / 97 / 9
Accruals ratio βˆ’10.7%βˆ’1.4%βˆ’2.1%
Altman Z'' 1.611.722.31

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
KBR KBR $5.0B 1.0% 10.0% 6.6% 15.8% 11.8x 7
Science Applications Intl SAIC $6.2B βˆ’2.9% 7.2% 8.0% 12.8% 17.0x 7 Compare β†’
CACI International CACI $14.1B 10.9% 9.6% 8.2% 8.8% 26.0x 5 Compare β†’
Cintas CTAS $90.6B 8.9% 23.1% 16.7% 31.7% 44.2x 8 Compare β†’
Copart CPRT $27.8B 0.4% 35.4% 27.2% 19.6% β€” 4 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $4.3B $4.2B $4.9B $5.6B $5.8B $7.3B $6.6B $7.0B $7.7B $7.8B
Gross profit $112M $439M $584M $653M $666M $806M $828M $977M $1.1B $1.2B
Operating income $28.0M $264M $468M $362M $57.0M $231M $343M $449M $659M $778M
Interest expense $13.0M $21.0M $66.0M $99.0M $72.0M $80.0M $87.0M $115M $144M $158M
Pretax income $33.0M $247M $396M $268M βˆ’$14.0M $146M $284M βˆ’$165M $508M $614M
Income tax $84.0M βˆ’$193M $86.0M $59.0M $28.0M $111M $92.0M $95.0M $129M $156M
Net income βˆ’$61.0M $432M $281M $202M βˆ’$63.0M $27.0M $190M βˆ’$265M $375M $415M
Diluted EPS βˆ’$0.43 $3.05 $1.99 $1.41 βˆ’$0.44 $0.19 $1.26 βˆ’$1.96 $2.79 $3.21
Diluted shares 0.14B 0.14B 0.14B 0.14B 0.14B 0.14B 0.16B 0.14B 0.13B 0.13B
Cash flow
Cash from operations $61.0M $193M $165M $256M $367M $278M $396M $331M $462M $557M
Capital expenditure $11.0M $8.0M $17.0M $20.0M $20.0M $30.0M $71.0M $62.0M $52.0M $42.0M
Free cash flow $50.0M $185M $148M $236M $347M $248M $325M $269M $410M $515M
Depreciation and amortization $45.0M $48.0M $63.0M $104M $115M $146M $137M $141M $156M $169M
Stock-based compensation $18.0M $12.0M $10.0M $12.0M $12.0M $12.0M β€” β€” β€” β€”
Acquisitions $911M $4.0M $354M $0.0M $832M $399M $73.0M $0.0M $738M $14.0M
Share buybacks $4.0M $53.0M $3.0M $4.0M $51.0M $82.0M $203M $138M $218M $329M
Dividends paid $46.0M $45.0M $44.0M $46.0M $54.0M $61.0M $66.0M $72.0M $79.0M $84.0M
Dividends and buybacks $50.0M $98.0M $47.0M $50.0M $105M $143M $269M $210M $297M $413M
Balance sheet
Cash and short-term investments $536M $439M $739M $712M $436M $370M $389M $304M $342M $500M
Total debt $650M $470M $1.2B $1.2B $1.6B $1.9B $1.7B $1.8B $2.6B $2.6B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $23.0M $20.0M $19.0M $21.0M $16.0M $9.0M
Current assets $2.0B $1.4B $2.0B $2.0B $1.6B $2.2B $1.7B $1.7B $1.9B $2.1B
Current liabilities $1.6B $1.1B $1.4B $1.5B $1.5B $1.9B $1.8B $1.6B $1.8B $1.7B
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Property and equipment, net $145M $130M $121M $130M $130M $136M $182M $239M $237M $232M
Total assets $4.1B $3.7B $5.1B $5.4B $5.7B $6.2B $5.6B $5.6B $6.7B $6.6B
Total liabilities $3.4B $2.5B $3.3B $3.5B $4.1B $4.5B $3.9B $4.2B $5.2B $5.1B
Shareholders' equity $757M $1.2B $1.7B $1.8B $1.6B $1.7B $1.6B $1.4B $1.5B $1.5B
Margins
Gross margin 2.6% 10.5% 11.9% 11.6% 11.6% 11.0% 12.6% 14.1% 14.3% 14.8%
Operating margin 0.7% 6.3% 9.5% 6.4% 1.0% 3.2% 5.2% 6.5% 8.6% 10.0%
EBITDA margin 1.7% 7.5% 10.8% 8.3% 3.0% 5.1% 7.3% 8.5% 10.6% 12.2%
Net margin βˆ’1.4% 10.4% 5.7% 3.6% βˆ’1.1% 0.4% 2.9% βˆ’3.8% 4.9% 5.3%
FCF margin 1.2% 4.4% 3.0% 4.2% 6.0% 3.4% 5.0% 3.9% 5.3% 6.6%
Returns
Return on capital 2.8% 25.5% 21.2% 12.3% 1.8% 3.9% 7.5% 11.9% 14.8% 15.8%
Return on capital employed 1.2% 10.2% 15.0% 9.7% 1.4% 5.4% 8.5% 11.6% 14.9% 15.9%
Return on equity βˆ’6.7% 43.5% 19.2% 11.4% βˆ’3.7% 1.7% 11.6% βˆ’17.7% 26.5% 28.1%
Return on assets βˆ’1.6% 11.1% 6.4% 3.9% βˆ’1.1% 0.5% 3.2% βˆ’4.8% 6.1% 6.3%
Growth
Revenue growth βˆ’16.3% βˆ’2.3% 17.8% 14.8% 2.3% 27.3% βˆ’10.6% 6.0% 10.8% 1.0%
Net income growth βˆ’130.1% β€” βˆ’35.0% βˆ’28.1% βˆ’131.2% β€” 603.7% βˆ’239.5% β€” 10.7%
EPS growth βˆ’130.7% β€” βˆ’34.8% βˆ’29.2% βˆ’131.2% β€” 563.2% βˆ’255.6% β€” 15.1%
FCF growth 35.1% 270.0% βˆ’20.0% 59.5% 47.0% βˆ’28.5% 31.1% βˆ’17.2% 52.4% 25.6%
Share count change βˆ’1.4% βˆ’0.7% 0.0% 0.7% 0.0% βˆ’0.7% 10.6% βˆ’13.5% βˆ’0.7% βˆ’3.7%
Financial health
Net debt / EBITDA 1.6x 0.1x 1.0x 1.1x 6.9x 4.1x 2.9x 2.6x 2.8x 2.2x
Debt / equity 0.9x 0.4x 0.7x 0.7x 1.0x 1.1x 1.1x 1.3x 1.8x 1.7x
Interest coverage 2.2x 12.6x 7.1x 3.7x 0.8x 2.9x 3.9x 3.9x 4.6x 4.9x
Current ratio 1.3x 1.3x 1.4x 1.3x 1.1x 1.2x 1.0x 1.1x 1.1x 1.2x
Quick ratio 1.3x 1.3x 1.4x 1.3x 1.1x 1.2x 1.0x 1.1x 1.1x 1.2x
Capital allocation
Capex / revenue 0.3% 0.2% 0.4% 0.4% 0.4% 0.4% 1.1% 0.9% 0.7% 0.5%
Stock comp / revenue 0.4% 0.3% 0.2% 0.2% 0.2% 0.2% β€” β€” β€” β€”
Payouts / FCF 100.0% 53.0% 31.8% 21.2% 30.3% 57.7% 82.8% 78.1% 72.4% 80.2%
Quality scores
Piotroski F-score 4.0 7.0 6.0 4.0 3.0 7.0 6.0 6.0 8.0 7.0
Altman Z'' 1.4 2.4 2.7 2.5 1.4 1.6 1.6 1.6 1.7 2.3
Accruals ratio βˆ’3.2% 6.1% 2.7% βˆ’1.0% βˆ’7.8% βˆ’4.2% βˆ’3.5% βˆ’10.7% βˆ’1.4% βˆ’2.1%

Source: SEC EDGAR XBRL filings (CIK 0001357615). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open